• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apogee Therapeutics, Inc. - Common Stock (NQ:APGE)

134.08 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 134.08
Bid (Size) 133.81 (500)
Ask (Size) 134.47 (1,500)
Prev. Close 134.08
Today's Range 134.08 - 134.08
52wk Range 34.34 - 134.40
Shares Outstanding 56,367,802
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow ↗
July 21, 2026
It looks like a great buy-and-hold option. 
Via The Motley Fool
Topics Intellectual Property
News headline image
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? ↗
July 19, 2026
There's no need to panic. 
Via The Motley Fool

Performance

YTD
+76.9%
+76.9%
1 Month
+1.2%
+1.2%
3 Month
+47.9%
+47.9%
6 Month
+63.7%
+63.7%
1 Year
+238.6%
+238.6%

More News

Read More
News headline image
My 2 Favorite Dividend Kings to Buy Right Now ↗
July 19, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Halper Sadeh LLC is Investigating Whether NEE, CRBG, RMAX, APGE are Obtaining Fair Deals for their Shareholders
July 14, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
What This Apogee Insider Move Might Mean After a 247% Stock Run ↗
July 12, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty ↗
July 11, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
The Dividend ETF Quietly Outperforming the S&P 500 ↗
July 07, 2026
Via The Motley Fool
Topics ETFs Stocks
News headline image
Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders
July 02, 2026
From Ademi LLP
Via GlobeNewswire
News headline image
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy? ↗
June 30, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
June 24, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether APGE, LPRO, HUN, AVNS are Obtaining Fair Deals for their Shareholders
June 23, 2026
From Halper Sadeh LLC
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume. ↗
June 23, 2026
Via Chartmill
News headline image
Why AbbVie Stock Jumped Today ↗
June 22, 2026
Via The Motley Fool
News headline image
AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King? ↗
June 22, 2026
Via The Motley Fool
News headline image
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer ↗
June 22, 2026
Via The Motley Fool
Topics Stocks
Top movers analysis one hour before the close of the markets on 2026-06-22: top gainers and losers in today's session. ↗
June 22, 2026
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
June 22, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
Which stocks are moving on Monday? ↗
June 22, 2026
Via Chartmill
Monday's session: gap up and gap down stocks ↗
June 22, 2026
Via Chartmill
News headline image
APGE Stock Alert: Halper Sadeh LLC is Investigating Whether Apogee Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
June 22, 2026
From Halper Sadeh LLC
Via Business Wire
These stocks that are showing activity before the opening bell on Monday. ↗
June 22, 2026
Via Chartmill
News headline image
Apogee Therapeutics Maps Phase 3 Push for Zumilokibart, Backed by Blackstone Funding ↗
June 10, 2026
Via MarketBeat
Topics Initial Public Offering
News headline image
Apogee Therapeutics Readies Zumi for Phase 3 With Blackstone Backing ↗
June 04, 2026
Via MarketBeat
Topics Initial Public Offering
News headline image
Apogee Therapeutics to Participate in Upcoming June Conferences
May 28, 2026
From Apogee Therapeutics
Via GlobeNewswire
News headline image
Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart
May 27, 2026
From Apogee Therapeutics
Via GlobeNewswire

Frequently Asked Questions

Is Apogee Therapeutics, Inc. - Common Stock publicly traded?
Yes, Apogee Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Apogee Therapeutics, Inc. - Common Stock trade on?
Apogee Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Apogee Therapeutics, Inc. - Common Stock?
The ticker symbol for Apogee Therapeutics, Inc. - Common Stock is APGE on the Nasdaq Stock Market
What is the current price of Apogee Therapeutics, Inc. - Common Stock?
The current price of Apogee Therapeutics, Inc. - Common Stock is 134.08
When was Apogee Therapeutics, Inc. - Common Stock last traded?
The last trade of Apogee Therapeutics, Inc. - Common Stock was at 07/22/26 04:00 PM ET
What is the market capitalization of Apogee Therapeutics, Inc. - Common Stock?
The market capitalization of Apogee Therapeutics, Inc. - Common Stock is 7.56B
How many shares of Apogee Therapeutics, Inc. - Common Stock are outstanding?
Apogee Therapeutics, Inc. - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap